rfhg_5363.1

Basic information about the TSS

---

TSS ID: rfhg_5363.1 Species: human Chr: chr1		Start: 37980350 End: 37980385 Strand: -
Source datasets	PRJNA4843412
Protocol	NETCAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000488934.1:-404 GeneID: 10946 HGNC/MGI_ID: HGNC:10767 UniProt_ID: Nearer transcript ids and distances:

Gene_name: splicing factor 3a subunit 3 Gene_symbol: SF3A3 Gene_synonyms: PRP9 PRPF9 SAP61 SF3a60 Gene_source: HGNC:10767

TATA-Box annotation

---

Distance to TSS:	9655
Nearest PromoterID:	NM_006802
Entrez ID:	10946
Nearest Unigene:	Hs.77897
Nearest Refseq:	NM_006802
Nearest Ensembl:	ENSG00000183431
Gene Name:	splicing factor 3a subunit 3
Gene Alias:	PRP9|PRPF9|SAP61|SF3a60
Gene Type:	protein-coding
CpG%:	0.085714
GC%:	0.638889
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SF3A3 p2@SF3A3 p3@SF3A3
Sample		p1@SF3A3	p2@SF3A3	p3@SF3A3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	73.64	5.45	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	67.98	6.27	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	77.16	5.98	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	63.20	6.45	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	69.29	7.65	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	70.74	5.43	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	115.26	8.06	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	93.01	7.02	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	85.06	6.41	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	73.03	6.96	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	55.38	6.87	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	59.76	2.85	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	22.89	3.55	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	24.66	3.16	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	15.81	2.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	17.86	4.28	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	16.82	2.84	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	17.72	2.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.46	4.27	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	16.40	3.31	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	18.71	2.94	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	25.20	4.14	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	19.00	3.36	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	18.69	2.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	25.03	3.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	16.46	2.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	22.53	2.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	20.27	2.83	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	14.05	2.42	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	19.00	2.90	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.96	3.56	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	13.68	1.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	16.25	2.95	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	32.49	5.11	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	17.76	2.99	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	15.71	3.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	16.96	3.27	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	20.35	4.23	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	20.80	2.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	19.93	1.68	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	17.64	2.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	26.35	4.10	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.40	2.11	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	14.86	2.97	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.68	3.21	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	14.66	2.56	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	15.35	2.16	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	19.08	2.09	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	17.71	3.83	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.42	2.83	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	14.76	3.28	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	13.79	4.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	685.62	83.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	13.13	4.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.27	2.98	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	109.06	11.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	40.87	4.59	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.70	3.57	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.35	4.82	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	23.89	5.97	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	13.40	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	9.53	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	23.88	3.18	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	21.41	3.06	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.07	1.30	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.16	1.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	711.21	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	600.21	63.18	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.80	2.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.40	1.98	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.57	1.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	14.57	2.32	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	8.04	2.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.87	2.45	0.00
Adipocyte - breast, donor1	11376-118A8	35.32	6.34	0.63
Adipocyte - breast, donor2	11327-117E4	20.70	4.17	0.80
Adipocyte - omental, donor1	11473-119C6	35.37	7.51	0.64
Adipocyte - omental, donor2	11474-119C7	23.92	2.24	0.75
Adipocyte - omental, donor3	11475-119C8	15.74	3.01	0.00
Adipocyte - perirenal, donor1	11476-119C9	15.95	3.19	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	41.10	10.39	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	23.98	6.43	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	36.38	4.89	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	25.74	5.66	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	26.20	6.41	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	27.04	8.82	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	38.93	7.72	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	21.95	5.81	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	19.73	3.73	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	22.81	8.90	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	19.13	4.57	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	20.34	4.77	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	18.98	3.27	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	15.83	2.44	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	19.01	3.09	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	5.38	0.36	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	12.95	3.78	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	9.86	1.64	0.00
Anulus Pulposus Cell, donor1	11248-116E6	47.94	5.38	0.34
Anulus Pulposus Cell, donor2	11463-119B5	17.88	1.47	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	22.91	4.04	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	19.10	6.08	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	22.72	7.17	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	26.56	6.32	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	17.16	2.64	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	21.12	4.22	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	23.79	7.28	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	16.63	7.72	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	27.87	7.91	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	19.59	5.08	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	17.55	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	33.77	7.08	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	21.84	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.89	4.67	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	28.40	8.57	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	22.67	5.48	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	20.31	4.54	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	16.58	1.95	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	22.89	5.14	1.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	25.56	5.15	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	20.87	4.37	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	26.18	5.31	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	7.27	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	27.36	6.84	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	21.38	4.70	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.65	4.39	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	20.18	3.28	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	20.26	7.40	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	21.40	6.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.30	9.36	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.37	6.32	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	32.04	6.61	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	31.07	5.09	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	21.60	2.54	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	19.42	4.32	2.59
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	18.63	2.75	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	20.01	4.35	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.95	4.72	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	21.70	4.24	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	6.95	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	8.45	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	22.94	1.72	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	17.45	3.01	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	22.60	5.10	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	23.68	4.83	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	19.07	3.56	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	25.80	4.95	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	19.89	3.98	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	25.33	5.26	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	23.50	5.54	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	7.63	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	22.71	3.88	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	25.42	5.03	1.85
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	13.08	5.45	1.09
Astrocyte - cerebellum, donor1	11500-119F6	25.55	3.07	0.37
Astrocyte - cerebellum, donor2	11580-120F5	11.98	4.11	0.17
Astrocyte - cerebellum, donor3	11661-122F5	3.99	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	73.90	7.32	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	64.39	7.93	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	52.50	6.86	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	135.67	12.50	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	155.73	14.91	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	140.20	15.93	1.25
Basophils, donor1	12241-129G9	15.95	3.14	0.00
Basophils, donor2	12242-129H1	42.57	8.66	0.36
Basophils, donor3	12243-129H2	21.17	3.38	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	5.61	1.51	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	1.37	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	26.36	4.39	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	32.65	4.99	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	19.34	3.22	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	19.07	5.58	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	117.38	9.79	1.03
Burkitt's lymphoma cell line:RAJI	10476-106I8	132.29	10.01	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	100.73	6.40	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	13.53	3.94	0.56
CD14+ Monocytes, donor2	11305-117B9	13.36	2.04	0.19
CD14+ Monocytes, donor3	11381-118B4	11.20	3.73	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	35.10	12.45	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	34.87	12.89	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	37.48	14.14	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	14.74	2.46	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	7.54	0.91	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	12.08	2.37	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.03	0.84	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	5.80	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	6.45	1.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	7.24	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.30	0.53	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	14.15	1.74	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.62	1.17	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	9.50	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	9.98	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	10.86	1.64	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	8.78	1.80	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.66	1.87	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	10.30	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	9.95	1.58	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	8.29	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	9.15	1.88	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	8.55	1.57	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	10.94	1.68	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.06	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.93	1.76	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	7.02	1.32	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	6.10	1.57	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	7.06	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	11.86	1.29	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	8.60	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	5.10	0.93	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.12	0.93	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	47.08	10.24	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	37.19	7.62	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	38.56	12.13	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	44.85	9.81	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	23.40	6.46	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	39.69	12.26	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	39.30	7.91	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	38.86	8.78	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	51.16	8.42	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	52.84	12.19	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	75.26	17.63	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	54.89	25.89	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	67.70	14.39	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	75.05	31.09	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	80.72	23.87	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	71.38	25.10	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	64.60	29.00	2.64
CD19+ B Cells, donor1	11544-120B5	27.94	8.22	0.82
CD19+ B Cells, donor2	11624-122B4	24.66	5.08	0.73
CD19+ B Cells, donor3	11705-123B4	26.76	6.06	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	177.79	29.50	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	106.26	18.78	1.20
CD34+ Progenitors, donor1	11545-120B6	32.13	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	30.90	1.69	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	109.72	7.14	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	123.56	9.02	0.68
CD4+ T Cells, donor1	11225-116C1	69.27	21.07	1.79
CD4+ T Cells, donor2	11306-117C1	39.19	15.31	1.22
CD4+ T Cells, donor3	11382-118B5	34.46	12.50	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	65.34	22.21	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	61.76	22.24	1.80
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	50.31	20.98	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	58.79	19.44	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	68.83	21.07	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	19.78	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	49.57	18.64	2.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	36.10	12.88	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	31.60	12.25	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	50.21	20.62	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	55.90	18.17	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	65.56	33.00	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	57.34	16.87	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	33.24	11.43	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	22.72	5.68	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	57.38	23.66	4.35
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	66.46	31.09	3.22
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	59.18	37.66	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	74.91	21.32	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	47.87	18.41	2.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	47.91	16.18	1.89
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	49.04	15.67	3.54
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	47.22	24.26	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	64.94	34.43	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	75.22	43.55	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	67.39	33.23	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	64.21	25.12	6.98
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	91.11	28.80	2.77
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	108.22	38.53	5.40
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	67.76	53.90	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	78.79	40.47	3.58
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	70.63	37.39	4.15
CD8+ T Cells, donor1	11226-116C2	62.21	17.35	2.95
CD8+ T Cells, donor2	11307-117C2	34.92	7.88	0.38
CD8+ T Cells, donor3	11383-118B6	46.71	12.88	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	35.79	6.19	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	34.51	6.23	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	37.48	5.47	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	49.53	5.70	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	27.84	5.76	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	35.47	4.78	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	39.55	6.08	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	34.48	6.32	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	38.70	4.46	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.02	3.62	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	36.02	2.61	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	41.03	3.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	21.01	3.06	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	20.95	3.19	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	24.61	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	36.02	3.24	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	33.95	5.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	29.46	3.54	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	51.66	6.34	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	50.13	6.46	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	40.71	5.13	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	36.72	2.29	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	33.50	3.55	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	35.55	2.27	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.89	2.41	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	23.78	4.20	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	21.04	4.01	0.00
Cardiac Myocyte, donor1	11525-119I4	25.59	7.31	0.00
Cardiac Myocyte, donor2	11605-120I3	27.67	2.47	0.49
Cardiac Myocyte, donor3	11686-122I3	43.78	6.42	0.42
Chondrocyte - de diff, donor1	11261-116G1	36.05	4.85	0.35
Chondrocyte - de diff, donor2	11338-117F6	24.52	4.26	1.07
Chondrocyte - de diff, donor3	11410-118E6	24.92	2.28	0.68
Chondrocyte - re diff, donor2	11339-117F7	89.53	9.85	0.00
Chondrocyte - re diff, donor3	11411-118E7	23.86	3.64	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	72.87	8.49	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	34.63	6.20	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	37.17	4.25	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	56.76	9.63	1.01
Corneal Epithelial Cells, donor1	11526-119I5	6.37	1.32	0.22
Corneal Epithelial Cells, donor2	11606-120I4	10.24	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.97	2.56	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	35.83	9.91	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	37.22	11.99	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	6.90	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.76	5.83	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	40.31	5.81	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	41.78	6.53	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	37.26	5.81	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	63.71	14.84	1.83
Endothelial Cells - Aortic, donor1	11263-116G3	34.03	10.56	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	38.74	9.90	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	25.16	10.22	0.39
Endothelial Cells - Artery, donor1	11264-116G4	19.49	6.69	0.00
Endothelial Cells - Artery, donor2	11341-117F9	37.88	11.29	1.18
Endothelial Cells - Artery, donor3	11413-118E9	51.72	12.27	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	30.37	12.41	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	32.56	13.69	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	28.19	8.46	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	27.04	5.05	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	28.12	7.81	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	8.79	3.26	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	66.82	9.60	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	16.25	3.67	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	95.79	21.62	1.86
Endothelial Cells - Umbilical vein, donor2	11324-117E1	38.89	16.51	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	46.53	18.93	1.59
Endothelial Cells - Vein, donor1	11267-116G7	35.26	5.69	3.41
Endothelial Cells - Vein, donor2	11344-117G3	46.10	4.19	1.40
Endothelial Cells - Vein, donor3	11416-118F3	29.67	8.48	0.94
Eosinophils, donor1	12244-129H3	60.99	30.49	0.00
Eosinophils, donor2	12245-129H4	8.25	1.65	1.65
Eosinophils, donor3	12246-129H5	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	8.06	1.47	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	19.29	4.93	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.74	2.63	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	17.23	2.93	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	51.42	6.79	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	52.13	7.10	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	20.99	4.11	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	37.15	2.11	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	41.86	7.31	0.66
Fibroblast - Cardiac, donor1	11268-116G8	26.76	3.18	0.00
Fibroblast - Cardiac, donor2	11345-117G4	19.71	3.03	0.00
Fibroblast - Cardiac, donor3	11417-118F4	15.14	1.73	0.32
Fibroblast - Cardiac, donor4	11452-119A3	56.68	7.88	0.61
Fibroblast - Cardiac, donor5	11456-119A7	28.81	5.71	1.02
Fibroblast - Cardiac, donor6	11460-119B2	41.99	5.76	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	16.21	2.01	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	24.16	3.02	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	51.27	5.86	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	18.91	2.31	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	42.74	5.09	0.68
Fibroblast - Dermal, donor1	11269-116G9	30.52	6.10	0.00
Fibroblast - Dermal, donor2	11346-117G5	73.58	7.08	1.89
Fibroblast - Dermal, donor3	11418-118F5	26.23	5.08	0.73
Fibroblast - Dermal, donor4	11450-119A1	57.65	9.16	1.24
Fibroblast - Dermal, donor5	11454-119A5	59.31	11.34	1.22
Fibroblast - Dermal, donor6	11458-119A9	65.78	12.83	2.44
Fibroblast - Gingival, donor1	11237-116D4	47.48	9.79	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	37.99	5.24	0.26
Fibroblast - Gingival, donor2	11318-117D4	58.38	10.02	0.92
Fibroblast - Gingival, donor3	11394-118C8	31.62	5.99	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	39.48	8.31	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	16.21	3.17	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	58.31	4.99	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	42.33	4.73	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	13.41	2.82	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	37.00	4.39	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	52.22	6.68	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	53.86	7.02	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	24.51	4.84	0.59
Fibroblast - Lung, donor1	11270-116H1	27.19	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	65.65	13.43	0.00
Fibroblast - Lung, donor3	11419-118F6	45.58	7.60	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	14.16	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.64	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	34.51	6.50	0.41
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	89.42	14.74	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	72.66	9.40	1.52
Fibroblast - Periodontal Ligament, donor3	11395-118C9	81.09	13.46	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	32.44	3.82	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	32.94	2.97	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	23.31	3.60	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	67.09	9.62	0.88
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	18.90	3.25	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	24.06	3.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	26.09	3.56	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	69.06	5.16	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	38.01	4.80	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	38.43	8.87	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	55.06	3.91	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	68.77	7.45	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	55.42	2.53	0.51
Fibroblast - skin normal, donor1	11553-120C5	37.57	6.56	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	96.64	7.42	0.40
Fibroblast - skin normal, donor2	11561-120D4	55.25	4.92	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	81.30	6.65	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	41.59	8.37	0.75
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	56.93	6.50	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	36.46	3.94	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	69.35	5.54	0.96
Fibroblast - skin walker warburg, donor1	11554-120C6	69.83	7.25	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	36.70	6.59	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1396.07	155.12	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.89	3.49	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	33.11	7.28	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	42.16	9.11	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	43.69	5.88	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	71.96	8.42	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	122.51	7.02	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	118.38	17.69	3.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	62.87	2.76	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	53.20	5.25	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	78.66	9.11	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	56.30	3.70	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	52.18	7.83	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	102.15	19.90	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	105.43	5.65	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	90.39	5.17	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	94.29	5.10	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	63.81	4.71	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	77.80	5.12	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	75.63	3.86	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	58.19	7.30	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	60.17	7.22	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	43.72	6.34	1.53
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	52.30	5.91	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	68.67	6.36	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	55.63	8.49	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	61.70	6.65	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	73.46	6.96	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	98.34	13.12	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	85.12	10.41	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	83.85	7.51	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	50.79	6.53	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	92.43	10.90	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	90.04	12.05	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	49.10	4.33	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	49.11	5.42	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	48.36	4.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	40.12	5.73	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	50.92	5.78	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	50.41	5.51	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	36.56	5.13	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	37.52	5.02	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	37.33	5.38	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	43.18	4.87	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	45.37	4.39	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	33.15	4.61	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	39.00	5.89	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	39.90	5.93	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	43.85	5.08	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	39.93	8.11	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	35.49	6.99	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	31.72	6.23	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	33.55	4.61	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	35.97	5.04	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	36.69	6.94	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	34.03	3.83	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	33.49	3.83	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	44.73	8.13	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	197.67	9.36	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	112.32	3.24	1.69
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	153.64	9.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	89.81	9.70	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	104.26	4.80	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	88.09	4.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	115.66	9.67	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	81.83	4.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	78.25	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	98.62	10.09	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	93.48	11.12	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	83.06	6.15	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	83.67	5.56	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	61.24	8.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	73.79	9.54	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	74.05	6.79	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	68.91	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	76.17	9.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	54.46	5.62	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	64.38	3.39	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	92.78	8.70	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	88.14	8.74	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	64.20	6.92	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	65.85	5.87	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	35.45	4.68	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	68.58	5.01	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	79.77	6.85	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	41.99	5.19	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	41.04	3.02	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	57.48	6.61	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	58.63	6.78	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	62.66	5.92	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	42.50	3.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	43.18	4.67	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	49.59	6.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	39.84	5.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	47.16	1.19	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	62.60	4.85	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	31.96	6.85	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	18.71	2.49	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	40.48	4.50	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	22.84	3.17	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	19.63	3.34	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	75.43	12.53	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	74.27	13.34	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	70.98	11.15	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	76.41	13.34	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	77.58	13.54	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	71.04	10.55	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	67.25	8.97	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	63.82	9.26	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	66.96	9.29	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	12.31	2.24	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.03	2.16	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	7.93	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.29	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	57.00	3.32	0.35
Hepatocyte, donor1	11523-119I2	27.84	2.42	1.21
Hepatocyte, donor2	11603-120I1	32.32	18.31	1.08
Hepatocyte, donor3	11684-122I1	28.84	8.59	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	94.64	16.32	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	45.44	8.91	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	49.81	6.04	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	82.78	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	73.43	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	116.29	1.38	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	77.58	7.51	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	76.89	5.13	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	73.13	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	116.95	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	88.37	8.34	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	123.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	96.61	5.29	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	104.21	6.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	89.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	108.97	3.78	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	94.34	6.19	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	29.27	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	92.38	7.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	86.94	6.44	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	107.53	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	92.08	4.89	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	124.26	5.46	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	109.30	4.02	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	88.64	9.23	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	87.80	4.25	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	78.00	8.16	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	89.32	5.38	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	95.28	8.89	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	86.72	7.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	72.91	3.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	67.84	5.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	92.91	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	92.29	10.49	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	94.83	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	100.58	6.29	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	75.80	5.56	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	110.65	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	84.29	16.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	84.58	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	74.24	6.75	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	73.18	10.45	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	99.21	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	96.98	9.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	71.24	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	71.79	5.52	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	62.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	60.27	3.17	0.00
Keratinocyte - epidermal, donor1	11272-116H3	32.39	6.53	0.24
Keratinocyte - epidermal, donor2	11349-117G8	28.11	2.93	0.59
Keratinocyte - epidermal, donor3	11421-118F8	43.64	6.91	0.76
Keratinocyte - oral, donor1	11251-116E9	73.67	15.55	0.45
Keratocytes, donor1	11527-119I6	21.66	3.44	0.00
Keratocytes, donor2	11607-120I5	7.03	1.17	0.00
Keratocytes, donor3	11688-122I5	37.15	8.30	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	52.75	8.79	0.00
Lens Epithelial Cells, donor1	11529-119I8	36.68	8.63	0.00
Lens Epithelial Cells, donor2	11609-120I7	53.05	9.11	0.81
Lens Epithelial Cells, donor3	11690-122I7	52.67	7.06	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	39.96	8.89	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	20.65	3.91	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	32.27	6.14	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	26.35	5.91	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	19.86	4.73	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	25.44	6.04	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	19.29	9.03	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	14.16	2.78	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	21.11	6.47	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.99	3.96	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	21.71	4.07	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	16.48	3.89	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	20.21	4.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	22.90	4.77	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	25.00	4.26	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	20.94	4.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	16.52	4.68	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	29.10	8.60	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	20.73	3.95	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	18.45	4.98	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	18.92	4.73	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	26.19	4.85	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	23.43	3.23	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	27.10	6.51	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	22.81	3.11	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	19.47	4.19	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	25.41	5.11	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	19.26	2.06	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	18.06	3.01	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	24.81	4.35	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	23.26	2.91	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	18.52	2.32	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	25.65	3.72	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.99	4.81	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	20.51	4.45	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	18.84	3.16	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	25.41	3.86	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.04	2.13	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	28.13	3.78	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	25.96	4.27	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	16.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	17.27	2.80	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	24.35	6.09	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.33	1.96	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	15.07	3.53	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	41.83	6.06	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.83	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	20.59	5.07	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	43.05	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	30.69	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	31.17	2.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	35.54	4.65	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	27.43	4.22	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	22.42	3.74	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	32.46	4.64	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	32.12	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	44.56	5.65	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	38.10	4.94	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	37.36	4.50	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	58.12	5.55	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	29.78	4.11	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	34.23	3.18	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	27.32	2.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	36.17	3.57	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	33.62	5.34	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	37.98	3.78	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	30.06	4.29	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	41.59	4.89	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	35.40	7.71	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	29.15	6.17	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	40.18	4.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	34.55	4.94	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	31.09	6.88	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	33.20	6.09	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	41.00	6.01	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	37.25	5.16	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	29.93	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	44.52	5.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	35.67	3.96	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	23.79	6.56	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	31.63	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	33.75	4.31	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	35.85	5.23	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	33.44	4.46	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	29.72	5.17	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	36.82	5.99	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	34.98	3.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	38.01	3.02	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	27.02	4.98	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	32.65	5.16	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	37.04	3.22	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	28.95	6.06	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	31.48	8.15	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	46.52	3.49	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	25.39	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	32.41	5.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	34.16	8.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	39.86	3.83	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	42.42	4.93	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	22.58	3.76	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	40.23	4.53	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	29.29	5.41	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	34.42	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	44.53	10.24	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	35.58	6.26	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	31.67	4.62	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	34.25	4.67	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	35.88	3.94	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	30.75	2.80	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	37.54	6.62	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	37.03	4.24	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	38.48	3.54	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	39.41	4.81	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	34.59	3.98	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	28.56	3.65	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	27.67	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	45.22	3.42	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	28.40	7.23	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	18.14	3.63	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	34.86	5.07	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	35.72	4.80	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	24.71	4.60	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	37.54	4.63	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	33.25	3.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	31.21	2.84	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	40.35	3.33	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	30.54	5.48	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	35.49	6.68	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	35.31	3.25	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	36.13	4.68	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	34.75	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	46.88	4.45	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.94	2.75	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	44.46	3.56	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	45.02	3.99	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	33.74	5.37	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	33.38	4.38	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	42.32	7.13	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	53.03	10.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	31.17	4.64	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	39.49	6.24	0.00
Macrophage - monocyte derived, donor1	11232-116C8	36.47	9.12	0.23
Macrophage - monocyte derived, donor2	11313-117C8	30.46	7.16	0.55
Macrophage - monocyte derived, donor3	11389-118C3	22.15	5.51	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	30.27	7.43	0.53
Mallassez-derived cells, donor2	11929-125I3	45.95	8.87	1.27
Mallassez-derived cells, donor3	11930-125I4	47.95	9.87	0.83
Mammary Epithelial Cell, donor1	11273-116H4	97.25	11.86	0.80
Mammary Epithelial Cell, donor2	11350-117G9	77.89	9.56	0.58
Mammary Epithelial Cell, donor3	11422-118F9	34.67	5.24	0.00
Mast cell - stimulated, donor1	11487-119E2	133.55	33.22	4.07
Mast cell, donor1	11563-120D6	53.10	10.49	0.87
Mast cell, donor2	11565-120D8	42.50	13.97	0.89
Mast cell, donor3	11566-120D9	54.48	14.86	1.35
Mast cell, donor4	11567-120E1	39.18	11.17	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	57.78	11.87	1.11
Mast cell, expanded and stimulated, donor8	11942-126A7	44.36	8.17	1.17
Mast cell, expanded, donor5	11939-126A4	50.82	11.24	1.26
Mast cell, expanded, donor8	11941-126A6	38.49	9.04	1.00
Melanocyte - dark, donor1	11502-119F8	36.02	13.13	2.19
Melanocyte - dark, donor2	11582-120F7	25.96	2.42	1.73
Melanocyte - dark, donor3	11663-122F7	67.44	9.78	1.01
Melanocyte - light, donor1	11274-116H5	17.63	5.88	0.47
Melanocyte - light, donor2	11351-117H1	24.57	4.09	0.68
Melanocyte - light, donor3	11423-118G1	20.81	8.67	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	50.50	8.85	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	38.46	6.72	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	35.62	6.16	0.27
Meningeal Cells, donor1	11493-119E8	35.61	5.71	0.74
Meningeal Cells, donor2	11573-120E7	21.57	5.28	0.00
Meningeal Cells, donor3	11654-122E7	115.81	16.06	1.55
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	53.32	7.41	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	38.54	8.75	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	32.29	12.92	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	30.92	4.66	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	25.63	4.52	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	18.68	3.52	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	15.34	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.09	2.66	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	45.29	5.54	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	6.69	1.86	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	42.89	4.47	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.90	1.19	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.29	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	78.69	13.82	2.84
Mesenchymal stem cells - hepatic, donor0	11218-116B3	33.15	5.63	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	50.80	7.26	0.73
Mesothelial Cells, donor1	11247-116E5	28.64	6.63	1.59
Mesothelial Cells, donor2	12156-128G5	25.52	7.51	0.00
Mesothelial Cells, donor3	11402-118D7	20.45	4.05	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	14.85	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	17.49	7.39	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	16.49	5.01	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.63	4.96	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	17.22	4.36	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	18.02	6.26	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	12.57	2.79	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.02	5.28	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	14.65	4.75	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	18.58	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	19.76	4.18	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	2.63	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	15.70	2.55	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	3.68	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.41	2.98	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	10.06	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	9.28	2.26	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	15.21	3.57	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7.19	2.21	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.97	3.22	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	13.25	5.26	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.15	2.85	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	12.01	4.29	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.45	1.56	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.79	2.19	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.14	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.87	3.26	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.59	4.41	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.09	3.36	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.41	3.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.01	4.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	8.32	1.75	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	2.21	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.12	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	12.15	2.73	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.26	4.87	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	16.41	3.76	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.13	3.50	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.10	2.13	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12.34	5.89	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.07	3.33	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.33	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.16	1.81	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	14.61	5.01	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.93	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	16.50	4.55	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.01	2.49	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.48	3.63	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.44	3.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.81	1.91	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.01	2.94	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.27	5.69	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.32	1.98	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.01	3.50	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	21.67	4.86	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	6.83	3.03	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	20.17	5.40	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	16.47	3.20	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.87	3.91	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.11	3.82	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	17.88	3.17	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	15.25	2.89	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.76	2.98	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	3.56	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	17.41	3.29	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	13.68	4.21	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	13.05	2.97	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	14.90	3.73	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	13.89	6.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	10.39	3.73	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	30.65	7.92	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	2.21	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	23.45	5.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	31.53	8.02	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	23.23	4.04	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	14.76	4.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	23.15	4.09	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	18.44	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	20.25	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	11.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	45.67	6.52	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	39.42	6.03	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	25.09	6.79	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	11.35	3.34	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	6.26	2.92	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	55.71	11.98	2.09
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	39.90	9.58	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	145.17	31.24	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	6.70	2.09	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	11.39	2.79	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	6.76	1.62	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	17.03	3.78	1.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	534.47	111.35	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	12.91	1.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.91	1.89	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.99	2.04	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	7.19	3.10	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	20.41	2.00	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.77	2.65	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.60	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	30.52	6.89	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.23	1.95	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.75	3.17	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	4.60	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	5.78	1.61	1.61
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	32.07	7.24	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	121.37	25.28	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	19.38	2.67	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	2.54	2.12	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.02	3.56	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.87	1.72	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	433.33	54.17	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.66	2.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.72	1.80	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.36	3.17	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	5.57	2.79	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.38	2.65	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.21	3.26	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.10	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.07	2.71	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	3.53	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.32	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.44	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	2.30	1.91	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	19.96	3.93	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	20.78	2.87	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.74	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	112.41	20.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.93	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.98	1.26	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.36	2.72	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	5.54	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	24.94	6.80	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	177.03	10.12	0.00
Myoblast, donor1	11241-116D8	34.54	8.57	0.50
Myoblast, donor2	11322-117D8	30.88	8.25	0.58
Myoblast, donor3	11398-118D3	38.51	9.42	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	59.69	9.63	0.44
Natural Killer Cells, donor1	11230-116C6	53.20	10.46	0.92
Natural Killer Cells, donor2	11311-117C6	36.79	5.13	0.90
Natural Killer Cells, donor3	11387-118C1	34.60	7.73	0.37
Neural stem cells, donor1	11275-116H6	101.26	9.80	1.09
Neural stem cells, donor2	11352-117H2	123.24	7.70	1.93
Neurons, donor1	11494-119E9	88.76	7.97	1.14
Neurons, donor2	11574-120E8	87.18	5.28	0.22
Neurons, donor3	11655-122E8	61.66	3.29	1.64
Neutrophils, donor1	11233-116C9	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	5.80	0.00
Neutrophils, donor3	11390-118C4	4.28	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	49.99	7.84	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	17.26	1.63	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	16.85	2.81	0.20
Olfactory epithelial cells, donor1	11933-125I7	16.38	2.48	0.41
Olfactory epithelial cells, donor2	11934-125I8	27.79	4.05	0.87
Olfactory epithelial cells, donor3	11935-125I9	17.71	3.75	0.79
Olfactory epithelial cells, donor4	11936-126A1	19.58	4.09	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	72.22	12.64	1.20
Osteoblast - differentiated, donor1	11276-116H7	29.78	6.17	0.00
Osteoblast - differentiated, donor2	11353-117H3	17.15	3.43	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	3.10	0.62
Osteoblast, donor1	11277-116H8	73.88	5.67	0.59
Osteoblast, donor2	11354-117H4	70.93	7.73	2.11
Osteoblast, donor3	11426-118G4	44.25	6.04	1.07
Pancreatic stromal cells, donor1	11249-116E7	65.79	8.93	1.01
Pericytes, donor1	11491-119E6	6.01	0.67	0.11
Pericytes, donor2	11571-120E5	7.70	0.68	0.23
Pericytes, donor3	11652-122E5	7.12	1.42	0.41
Perineurial Cells, donor1	11499-119F5	50.29	7.57	0.79
Perineurial Cells, donor2	11579-120F4	54.65	7.73	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	48.77	21.04	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	24.49	7.59	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	23.94	9.45	0.91
Placental Epithelial Cells, donor1	11278-116H9	35.87	12.20	0.96
Placental Epithelial Cells, donor2	11355-117H5	22.18	2.22	1.11
Placental Epithelial Cells, donor3	11427-118G5	24.54	2.75	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	10.13	1.90	0.63
Preadipocyte - breast, donor1	11467-119B9	30.76	4.88	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	52.99	7.31	0.78
Preadipocyte - breast, donor2	11328-117E5	23.64	5.63	0.45
Preadipocyte - omental, donor1	11468-119C1	27.07	5.65	0.75
Preadipocyte - omental, donor2	11329-117E6	32.30	4.36	0.44
Preadipocyte - omental, donor3	11403-118D8	30.66	4.01	0.57
Preadipocyte - perirenal, donor1	11469-119C2	16.73	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	46.07	7.06	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	76.67	11.86	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	43.25	7.83	0.34
Preadipocyte - visceral, donor1	11280-116I2	83.93	13.13	1.02
Preadipocyte - visceral, donor2	11357-117H7	42.34	8.74	1.38
Preadipocyte - visceral, donor3	11429-118G7	42.95	6.58	1.36
Prostate Epithelial Cells (polarized), donor1	11253-116F2	65.47	14.33	1.06
Prostate Epithelial Cells, donor2	11331-117E8	17.47	5.96	0.14
Prostate Epithelial Cells, donor3	11404-118D9	18.13	5.51	0.24
Prostate Stromal Cells, donor1	11254-116F3	84.29	9.68	1.14
Prostate Stromal Cells, donor2	11332-117E9	50.38	7.35	0.72
Prostate Stromal Cells, donor3	11405-118E1	28.15	4.80	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.57	1.82	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	37.50	6.72	0.90
Renal Epithelial Cells, donor1	11517-119H5	6.59	2.03	0.51
Renal Epithelial Cells, donor2	11597-120H4	12.09	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	51.34	8.68	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	3.40	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	12.26	3.77	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	54.17	10.88	1.78
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.99	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	17.17	2.64	0.22
Renal Mesangial Cells, donor2	11598-120H5	10.03	3.76	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.44	0.83	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.30	4.56	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.33	0.84	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	15.04	2.31	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	61.45	12.96	1.81
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.35	4.55	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	13.38	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	39.39	9.28	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	37.28	15.64	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	30.38	5.36	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	96.87	12.66	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	80.05	10.44	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	92.71	5.98	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	53.92	4.67	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	92.69	10.26	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	113.87	11.04	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	58.62	6.29	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	72.34	8.32	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	54.76	6.57	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	64.90	8.17	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	73.47	9.86	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	55.52	5.59	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	59.88	8.26	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	61.29	8.85	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	49.32	6.50	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	59.72	6.34	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	94.71	10.90	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	52.55	6.24	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	65.02	6.91	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	64.16	8.02	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	52.01	5.87	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	61.39	6.17	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	69.38	7.52	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	48.32	6.56	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	50.65	5.64	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	60.98	8.19	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	56.61	7.31	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	51.59	4.56	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	67.82	9.59	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	58.68	6.64	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	71.01	9.95	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	60.99	11.49	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	63.93	7.00	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	61.14	6.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	62.47	7.52	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	59.15	9.80	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	57.06	7.27	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	68.79	8.54	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	46.70	5.11	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	70.87	7.40	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	47.18	4.26	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	41.34	4.29	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	58.81	5.71	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	60.46	9.07	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	40.87	3.11	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	47.86	7.34	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	35.96	4.84	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	48.83	4.28	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	93.30	7.28	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	51.11	5.48	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	54.85	4.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	50.21	6.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	49.42	4.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	84.90	4.13	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	43.33	4.27	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	49.28	6.61	0.00
Schwann Cells, donor1	11498-119F4	9.59	1.13	0.38
Schwann Cells, donor2	11578-120F3	37.43	6.80	0.00
Schwann Cells, donor3	11659-122F3	32.42	5.04	1.75
Sebocyte, donor1	11220-116B5	84.36	9.86	0.00
Sebocyte, donor2	11301-117B5	40.90	5.51	0.92
Sebocyte, donor3	11378-118B1	24.73	4.74	0.00
Sertoli Cells, donor1	11255-116F4	36.45	4.97	0.00
Sertoli Cells, donor2	11333-117F1	31.07	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	59.56	7.92	0.44
Skeletal Muscle Cells, donor2	11358-117H8	15.18	5.06	0.00
Skeletal Muscle Cells, donor3	11430-118G8	34.28	5.02	0.84
Skeletal Muscle Cells, donor4	11451-119A2	56.08	9.11	1.73
Skeletal Muscle Cells, donor5	11455-119A6	40.73	5.50	1.04
Skeletal Muscle Cells, donor6	11459-119B1	67.72	12.93	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	69.30	10.08	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	32.68	5.28	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	72.82	11.11	1.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	57.21	8.09	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	41.25	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	26.69	3.03	0.41
Skin - palm, donor1	10286-104F7	56.41	10.74	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.40	3.17	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	43.35	13.90	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	15.71	3.51	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	30.16	8.76	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	24.76	4.22	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	95.78	12.69	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	17.69	7.94	1.05
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	18.52	4.94	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	29.13	3.33	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	35.27	4.70	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	36.02	5.30	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	38.20	6.30	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	34.77	3.09	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	26.02	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	32.20	6.39	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	27.93	3.55	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	33.42	6.02	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	37.44	4.56	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	42.82	7.38	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.81	5.41	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.07	1.30	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	22.53	6.39	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	42.68	4.04	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	23.36	2.38	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	41.74	6.19	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	30.99	2.58	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	37.37	6.82	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	41.45	4.95	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	14.01	2.16	3.23
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	29.89	4.78	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	8.88	1.71	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	51.59	5.97	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	36.63	4.63	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	30.95	4.32	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	15.10	1.21	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	152.86	19.07	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	65.38	3.73	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	37.07	5.01	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	28.92	5.33	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	52.32	7.99	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.00	2.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	34.89	10.34	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	27.90	4.65	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	26.25	3.53	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	17.86	3.13	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.90	1.47	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	102.97	12.75	0.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.96	3.74	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	37.85	5.76	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	38.75	7.90	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	30.27	4.14	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	92.79	11.60	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	40.39	5.70	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.29	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	30.34	4.89	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	39.55	5.97	1.77
Smooth Muscle Cells - Uterine, donor3	11466-119B8	55.88	7.31	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	19.05	3.11	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.78	2.12	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	36.08	7.07	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	20.48	5.03	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	19.59	5.68	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	37.81	5.91	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	22.60	3.81	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	13.18	3.59	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	14.63	2.09	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	19.25	4.58	0.00
Synoviocyte, donor1	11291-117A4	25.92	4.88	0.17
Synoviocyte, donor2	11368-117I9	19.44	3.69	0.17
Synoviocyte, donor3	11440-118H9	18.32	3.35	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	26.44	2.50	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.36	1.85	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	51.54	8.89	0.93
Tracheal Epithelial Cells, donor2	11369-118A1	23.58	4.25	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	24.05	3.44	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	34.57	17.59	1.11
Urethra, donor2	10319-105A4	43.16	17.98	1.80
Urothelial Cells, donor1	11520-119H8	5.84	0.27	0.00
Urothelial Cells, donor2	11600-120H7	5.61	2.00	0.40
Urothelial Cells, donor3	11681-122H7	3.90	1.38	0.00
Urothelial cells, donor0	11216-116B1	31.43	6.69	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	40.93	12.46	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	40.03	10.01	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	20.54	7.53	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	35.47	14.12	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	35.44	19.75	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	29.15	15.62	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	42.22	16.52	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	20.08	10.04	0.00
Wilms' tumor cell line:G-401	10809-111A8	75.13	9.38	0.74
Wilms' tumor cell line:HFWT	10597-108E3	50.16	12.32	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	54.75	4.75	0.84
achilles tendon, donor2	10292-104G4	16.53	6.20	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	148.13	4.08	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	182.02	8.82	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	143.64	7.95	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	170.34	71.29	4.35
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	128.74	10.68	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	100.88	9.94	1.69
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	80.30	8.44	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	97.82	7.49	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	90.66	5.72	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	81.93	10.48	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	167.99	17.66	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	97.51	11.70	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	128.97	19.52	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	124.53	23.04	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	117.77	15.20	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	71.11	14.41	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	51.41	6.99	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	28.85	6.14	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	122.04	14.08	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	112.52	17.29	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	131.67	18.53	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	102.01	11.14	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	71.71	19.68	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	61.32	11.15	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	127.69	7.16	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	82.87	6.54	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	67.48	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	35.09	12.48	1.18
adipose tissue, adult, pool1	10010-101C1	43.12	11.79	0.47
adipose, donor1	10184-103D4	158.92	8.21	1.17
adipose, donor2	10185-103D5	25.55	3.65	1.22
adipose, donor3	10186-103D6	46.83	6.26	0.54
adipose, donor4	10187-103D7	66.74	4.33	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	74.33	16.73	1.89
adrenal gland, adult, pool1	10081-102A9	10.91	10.91	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	83.51	4.54	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	83.61	15.36	2.14
amniotic membrane cells, donor1	12235-129G3	40.57	12.52	0.70
amniotic membrane cells, donor2	12236-129G4	52.41	16.91	0.68
amniotic membrane cells, donor3	12237-129G5	33.88	15.32	1.18
amygdala - adult, donor10196	10167-103B5	37.95	8.30	0.00
amygdala, adult, donor10252	10151-102I7	49.68	7.91	1.01
amygdala, newborn, donor10223	10360-105E9	19.37	6.78	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	64.56	12.48	1.40
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	60.89	3.97	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	83.84	9.69	1.67
aorta, adult, pool1	10052-101G7	21.97	7.45	0.78
appendix, adult	10189-103D9	38.42	13.58	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	56.75	8.94	0.69
artery, adult	10190-103E1	20.38	9.51	0.00
astrocytoma cell line:TM-31	10425-106D2	67.36	11.30	1.45
b cell line:RPMI1788	10427-106D4	79.85	4.46	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	38.01	6.10	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	70.85	10.52	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	19.75	2.85	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	49.77	6.71	0.56
bladder, adult, pool1	10011-101C2	41.39	9.02	0.76
blood, adult, pool1	10053-101G8	15.50	8.86	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	30.83	5.99	0.00
bone marrow, adult	10192-103E3	33.07	10.12	0.67
brain, adult, donor1	10084-102B3	24.60	2.05	0.00
brain, adult, pool1	10012-101C3	53.12	6.24	0.11
brain, fetal, pool1	10085-102B4	45.41	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	44.93	14.87	2.97
breast carcinoma cell line:MDA-MB-453	10419-106C5	65.78	6.99	0.37
breast, adult, donor1	10080-102A8	10.10	7.58	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	45.48	9.78	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	59.99	7.73	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	73.44	16.35	2.99
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	34.38	6.54	0.48
carcinoid cell line:NCI-H1770	10703-109H1	128.36	16.46	0.47
carcinoid cell line:NCI-H727	10735-110B6	28.33	4.70	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	42.46	3.17	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	109.13	7.45	0.27
caudate nucleus - adult, donor10196	10177-103C6	32.24	9.21	0.00
caudate nucleus, adult, donor10252	10164-103B2	49.53	8.87	0.67
caudate nucleus, adult, donor10258	10379-105H1	24.45	6.11	1.53
caudate nucleus, newborn, donor10223	10354-105E3	22.34	7.32	0.73
cerebellum - adult, donor10196	10173-103C2	64.09	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	79.21	13.24	1.71
cerebellum, adult, pool1	10083-102B2	22.42	3.79	0.34
cerebellum, newborn, donor10223	10357-105E6	53.97	11.62	4.15
cerebral meninges, adult	10188-103D8	39.33	9.83	1.26
cerebrospinal fluid, donor2	10294-104G6	21.20	2.92	0.00
cervical cancer cell line:D98-AH2	10552-107I3	103.95	21.42	1.01
cervical cancer cell line:ME-180	10553-107I4	61.65	7.62	0.33
cervix, adult, pool1	10013-101C4	52.50	11.13	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	104.50	16.72	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	19.59	3.92	1.31
choriocarcinoma cell line:BeWo	10423-106C9	149.88	17.90	1.74
choriocarcinoma cell line:SCH	10785-110H2	57.54	7.89	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	73.29	14.47	1.66
chorionic membrane cells, donor1	12238-129G6	35.33	7.69	0.28
chorionic membrane cells, donor2	12239-129G7	65.82	8.25	0.50
chorionic membrane cells, donor3	12240-129G8	64.84	7.14	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	68.67	19.19	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	55.90	7.68	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	104.54	11.19	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	137.90	13.35	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	141.74	21.29	1.94
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	139.27	19.55	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	173.14	34.75	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	161.85	11.47	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	104.92	12.11	0.23
clear cell carcinoma cell line:TEN	10636-108I6	53.27	3.30	0.69
colon carcinoma cell line:CACO-2	10513-107D9	57.29	11.90	0.37
colon carcinoma cell line:COLO-320	10420-106C6	92.74	6.08	0.38
colon, adult, donor1	10082-102B1	28.56	8.33	1.19
colon, adult, pool1	10014-101C5	38.66	10.46	0.59
colon, fetal, donor1	10070-101I7	20.39	4.33	0.00
common myeloid progenitor CMP, donor1	12130-128D6	41.25	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	103.26	11.90	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	108.67	9.66	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	120.28	11.70	0.56
corpus callosum, adult, pool1	10042-101F6	58.05	10.17	1.33
cruciate ligament, donor2	10295-104G7	27.56	13.78	3.24
diaphragm, fetal, donor1	10069-101I6	11.24	5.62	0.00
diencephalon, adult	10193-103E4	32.16	6.24	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	95.06	9.87	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	104.88	18.21	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	65.72	17.57	1.20
ductus deferens, adult	10196-103E7	42.86	10.47	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	21.60	7.20	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	30.16	10.30	2.94
dura mater, adult, donor1	10041-101F5	60.04	3.96	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	123.92	13.99	1.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	161.92	13.90	1.72
embryonic pancreas cell line:1B2C6	10604-108F1	38.23	22.20	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	33.00	11.50	2.12
embryonic pancreas cell line:1C3IKEI	10606-108F3	44.46	14.20	0.93
embryonic pancreas cell line:2C6	10603-108E9	66.99	17.08	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	63.02	1.68	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	76.30	15.59	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	28.30	4.66	0.32
epidermoid carcinoma cell line:A431	10426-106D3	83.48	4.45	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	77.65	14.85	1.10
epididymis, adult	10197-103E8	34.95	6.07	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	45.77	7.27	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	21.63	8.26	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	129.87	15.86	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	121.94	11.02	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	121.44	18.04	1.34
esophagus, adult, pool1	10015-101C6	38.33	8.92	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	43.58	9.39	1.00
eye - muscle inferior rectus, donor1	10272-104E2	28.97	7.24	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	2.10	0.00
eye - muscle medial, donor2	10299-104H2	14.88	2.98	0.00
eye - muscle superior, donor2	10297-104G9	21.78	11.46	1.15
eye - vitreous humor, donor1	10268-104D7	29.15	4.37	0.00
eye, fetal, donor1	10054-101G9	29.49	5.85	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	64.88	10.64	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	87.13	26.12	4.04
frontal lobe, adult, pool1	10040-101F4	69.43	7.79	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	135.71	12.91	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	48.37	3.57	0.27
gall bladder, adult	10198-103E9	22.94	7.24	0.72
gamma delta positive T cells, donor1	11937-126A2	55.83	14.50	4.83
gamma delta positive T cells, donor2	11938-126A3	51.54	14.94	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	33.16	8.45	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	59.96	25.72	1.35
gastric cancer cell line:AZ521	10549-107H9	119.36	23.12	1.64
gastric cancer cell line:GSS	10560-108A2	19.22	1.83	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	101.66	7.31	1.37
giant cell carcinoma cell line:LU65	10487-107B1	47.16	11.13	1.26
giant cell carcinoma cell line:Lu99B	10433-106E1	59.76	8.82	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	50.13	5.99	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	37.68	4.96	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	33.28	6.18	0.56
glioblastoma cell line:T98G	10485-107A8	68.87	4.97	0.33
glioma cell line:GI-1	10413-106B8	62.68	8.20	0.29
globus pallidus - adult, donor10196	10175-103C4	19.68	7.29	0.73
globus pallidus, adult, donor10252	10161-103A8	51.75	16.11	0.73
globus pallidus, adult, donor10258	10367-105F7	31.49	9.58	1.37
globus pallidus, newborn, donor10223	10364-105F4	17.59	5.86	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	41.60	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	67.95	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	17.60	3.84	0.32
hIPS +CCl2, biol_rep1	14383-156B9	74.38	6.43	0.92
hIPS +CCl2, biol_rep2	14384-156C1	86.42	5.03	0.46
hIPS +CCl2, biol_rep3	14385-156C2	54.10	5.15	0.00
hIPS, biol_rep1	14380-156B6	73.30	18.68	1.44
hIPS, biol_rep2	14381-156B7	77.50	6.86	0.69
hIPS, biol_rep3	14382-156B8	24.28	4.41	0.00
hairy cell leukemia cell line:Mo	10712-109I1	59.77	7.18	0.57
heart - mitral valve, adult	10205-103F7	30.79	8.37	0.60
heart - pulmonic valve, adult	10206-103F8	31.64	8.63	0.52
heart - tricuspid valve, adult	10207-103F9	31.64	24.15	4.16
heart, adult, diseased post-infarction, donor1	10050-101G5	30.00	3.88	0.41
heart, adult, diseased, donor1	10051-101G6	22.14	2.55	0.85
heart, adult, pool1	10016-101C7	31.97	6.21	1.38
heart, fetal, pool1	10046-101G1	49.70	6.47	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	12.03	1.85	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	58.27	19.03	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	91.60	9.61	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	102.80	10.44	1.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	105.40	8.99	0.61
hepatoma cell line:Li-7	10484-107A7	30.25	3.78	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	152.66	15.08	1.41
hippocampus - adult, donor10196	10169-103B7	31.23	5.68	1.89
hippocampus, adult, donor10252	10153-102I9	51.43	12.04	0.41
hippocampus, adult, donor10258	10374-105G5	33.36	3.49	0.00
hippocampus, newborn, donor10223	10363-105F3	18.33	8.46	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	140.99	22.58	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	78.15	9.43	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	81.50	13.96	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	44.55	1.69	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	42.60	2.07	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	63.39	4.18	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	60.73	7.88	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	57.52	4.31	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	69.65	6.26	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	114.13	8.76	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	79.23	5.63	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	109.75	6.73	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	84.19	11.58	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	79.59	11.30	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	143.13	21.82	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	63.76	4.39	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	60.18	1.31	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	57.47	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	43.33	5.27	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	46.38	3.18	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	40.09	5.64	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	61.07	4.25	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	57.19	4.06	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	44.54	2.99	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	88.49	9.42	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	79.31	7.13	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	129.43	15.92	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	70.77	4.93	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	59.86	2.53	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	59.31	4.24	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	48.61	8.79	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	45.83	3.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	62.34	4.87	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	65.70	6.65	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	64.36	6.82	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	55.45	5.38	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	95.39	7.00	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	105.18	13.37	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	71.22	9.27	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	68.46	3.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	849.10	16.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	103.25	7.61	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	60.75	7.11	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	53.56	7.24	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	49.47	3.56	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	58.48	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	113.49	8.53	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	59.54	4.58	0.81
immature langerhans cells, donor1	11904-125F5	77.73	5.81	0.48
immature langerhans cells, donor2	11905-125F6	28.52	2.38	0.00
insula, adult, pool1	10039-101F3	70.50	7.95	0.85
keratoacanthoma cell line:HKA-1	10791-110H8	27.64	4.88	0.33
kidney, adult, pool1	10017-101C8	44.46	10.11	1.10
kidney, fetal, pool1	10045-101F9	46.61	10.19	0.92
large cell lung carcinoma cell line:IA-LM	10509-107D5	100.27	20.45	2.41
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.87	3.32	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	63.12	14.13	0.92
left atrium, adult, donor1	10079-102A7	10.90	2.72	1.09
left ventricle, adult, donor1	10078-102A6	16.18	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	47.61	13.41	0.00
leiomyoma cell line:10964C	10569-108B2	24.43	7.54	0.72
leiomyoma cell line:15242A	10570-108B3	19.02	6.52	1.09
leiomyoma cell line:15425	10571-108B4	36.67	6.07	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	60.64	5.23	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	140.49	7.67	0.94
liposarcoma cell line:KMLS-1	10782-110G8	27.18	5.78	0.16
liposarcoma cell line:SW 872	10726-110A6	45.32	3.78	0.37
liver, adult, pool1	10018-101C9	43.27	9.40	0.65
liver, fetal, pool1	10086-102B5	17.87	5.64	1.88
locus coeruleus - adult, donor10196	10182-103D2	32.96	6.71	0.00
locus coeruleus, adult, donor10252	10165-103B3	40.97	11.63	1.29
locus coeruleus, adult, donor10258	10375-105G6	16.93	2.26	0.85
locus coeruleus, newborn, donor10223	10362-105F2	42.06	9.25	1.26
lung adenocarcinoma cell line:A549	10499-107C4	31.55	8.72	0.97
lung adenocarcinoma cell line:PC-14	10408-106B3	48.95	8.27	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	59.58	5.67	0.40
lung, adult, pool1	10019-101D1	28.35	8.74	0.59
lung, fetal, donor1	10068-101I5	56.51	11.42	1.14
lung, right lower lobe, adult, donor1	10075-102A3	16.95	9.16	0.92
lymph node, adult, donor1	10077-102A5	26.51	6.15	0.00
lymphangiectasia cell line:DS-1	10727-110A7	37.92	5.48	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	146.70	9.96	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	88.35	7.65	0.00
mature adipocyte, donor1	12231-129F8	35.08	4.44	0.00
mature adipocyte, donor2	12232-129F9	44.62	10.79	0.62
mature adipocyte, donor3	12233-129G1	32.48	6.40	0.00
mature adipocyte, donor4	12234-129G2	43.96	6.05	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	118.65	17.63	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	40.61	4.51	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	54.99	12.14	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	30.50	4.77	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	66.53	9.38	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	48.26	6.41	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	52.63	10.82	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	588.50	57.41	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	23.33	8.26	1.08
medulla oblongata - adult, donor10196	10174-103C3	25.31	4.54	0.00
medulla oblongata, adult, donor10252	10155-103A2	40.87	13.93	1.70
medulla oblongata, adult, pool1	10038-101F2	54.61	9.47	0.65
medulla oblongata, newborn, donor10223	10361-105F1	19.79	9.72	1.74
medulloblastoma cell line:D283 Med	10838-111E1	104.95	4.87	0.00
medulloblastoma cell line:ONS-76	10759-110E3	68.23	9.17	0.86
melanoma cell line:COLO 679	10514-107E1	29.32	5.61	0.43
melanoma cell line:G-361	10465-106H6	50.22	8.14	0.81
meningioma cell line:HKBMM	10691-109F7	27.14	6.33	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	146.27	8.81	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	166.42	11.67	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	54.01	7.21	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	35.63	4.18	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	29.40	3.31	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	27.53	4.78	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	29.66	3.27	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	26.37	3.47	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	21.28	3.95	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	25.07	4.83	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	44.17	5.17	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	43.62	5.40	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	41.83	7.40	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	19.76	5.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	34.18	6.09	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	27.58	10.12	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	19.40	4.49	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	18.69	2.52	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	16.76	1.86	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	16.19	2.96	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	102.37	10.49	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	33.18	5.38	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	25.38	4.38	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	20.25	7.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	21.46	2.58	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	65.26	8.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	23.75	3.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	35.81	2.81	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	37.43	5.50	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.04	4.93	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	32.95	5.88	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	31.14	7.78	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	28.29	5.50	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	29.66	6.95	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	34.61	5.48	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	33.47	5.80	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	29.32	7.21	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	26.40	2.93	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	25.51	4.70	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	25.79	3.68	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	28.78	3.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	26.96	5.20	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	27.64	8.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.72	4.26	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	20.44	6.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	19.82	5.05	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	23.84	4.97	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	27.87	4.74	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	36.55	4.87	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	23.44	3.17	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	18.97	3.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	24.04	3.26	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.07	3.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.69	1.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	18.08	2.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	24.06	5.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	21.34	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	17.32	2.97	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	13.99	2.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.88	3.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	6.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	24.07	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.24	6.68	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	16.47	2.47	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	16.27	0.99	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.95	3.24	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	18.34	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	30.95	3.87	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	54.34	14.65	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	82.01	5.10	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	50.24	3.80	0.10
mesothelioma cell line:Mero-25	10850-111F4	32.91	3.18	0.23
mesothelioma cell line:Mero-41	10851-111F5	76.77	8.80	0.98
mesothelioma cell line:Mero-48a	10852-111F6	65.54	8.86	1.55
mesothelioma cell line:Mero-82	10853-111F7	33.38	2.37	0.26
mesothelioma cell line:Mero-83	10854-111F8	66.73	7.15	0.17
mesothelioma cell line:Mero-84	10855-111F9	29.83	1.52	0.00
mesothelioma cell line:Mero-95	10856-111G1	40.37	4.97	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	56.15	8.78	0.66
mesothelioma cell line:NCI-H226	10846-111E9	76.02	5.61	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	62.01	11.10	1.37
mesothelioma cell line:NCI-H28	10845-111E8	65.40	11.96	1.53
mesothelioma cell line:No36	10857-111G2	45.99	5.87	0.98
mesothelioma cell line:ONE58	10858-111G3	41.18	4.34	0.27
migratory langerhans cells, donor1	11901-125F2	270.61	13.43	1.54
migratory langerhans cells, donor2	11902-125F3	142.75	10.99	0.12
migratory langerhans cells, donor3	11903-125F4	200.66	6.82	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	21.22	3.26	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	37.94	5.51	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	35.94	9.21	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	40.91	5.52	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	152.64	19.77	1.11
myeloma cell line:PCM6	10474-106I6	51.59	3.95	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	39.06	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	58.65	8.43	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	29.86	9.92	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	31.03	10.66	0.66
nasal epithelial cells, donor2	12227-129F4	28.70	4.42	0.00
neuroblastoma cell line:CHP-134	10508-107D4	70.86	3.68	0.00
neuroblastoma cell line:NB-1	10539-107G8	67.16	5.24	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	199.29	9.07	1.05
neuroblastoma cell line:NH-12	10555-107I6	51.99	3.54	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	52.19	8.30	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	54.17	10.77	1.74
neuroectodermal tumor cell line:TASK1	10774-110F9	57.36	6.84	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	41.32	1.91	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	23.95	3.99	0.53
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	183.50	9.13	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	56.84	8.81	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	21.80	3.53	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	35.74	4.73	0.26
nucleus accumbens, adult, pool1	10037-101F1	63.27	10.12	0.66
occipital cortex - adult, donor10196	10172-103C1	49.45	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	57.70	13.69	1.34
occipital cortex, newborn, donor10223	10355-105E4	18.20	5.10	1.09
occipital lobe, adult, donor1	10076-102A4	27.55	2.89	0.79
occipital lobe, fetal, donor1	10073-102A1	35.62	5.15	0.43
occipital pole, adult, pool1	10036-101E9	49.67	5.05	0.47
olfactory region, adult	10195-103E6	38.40	4.78	0.57
optic nerve, donor1	10277-104E7	18.01	6.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	45.79	9.45	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	73.50	5.91	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	57.23	11.68	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	47.01	9.13	1.04
osteoclastoma cell line:Hs 706.T	10704-109H2	16.76	4.12	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	114.92	24.29	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	79.73	7.85	0.42
ovary, adult, pool1	10020-101D2	51.71	15.11	1.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	40.51	5.13	0.55
pancreas, adult, donor1	10049-101G4	33.86	15.99	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	44.17	7.27	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	54.68	8.52	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	28.98	5.46	1.32
paracentral gyrus, adult, pool1	10035-101E8	55.92	8.51	0.64
parietal cortex, adult, donor10258	10373-105G4	33.03	7.34	2.20
parietal lobe - adult, donor10196	10171-103B9	45.14	6.58	1.88
parietal lobe, adult, donor10252	10157-103A4	51.02	10.26	1.43
parietal lobe, adult, pool1	10034-101E7	61.24	6.52	0.53
parietal lobe, fetal, donor1	10072-101I9	38.79	5.82	1.94
parietal lobe, newborn, donor10223	10356-105E5	25.42	9.35	1.12
parotid gland, adult	10199-103F1	43.17	16.03	1.23
penis, adult	10200-103F2	41.36	7.52	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	68.80	10.97	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	30.16	4.23	0.15
pineal gland - adult, donor10196	10179-103C8	45.80	6.45	0.00
pineal gland, adult, donor10252	10160-103A7	62.77	15.99	1.18
pineal gland, adult, donor10258	10377-105G8	27.59	6.27	1.25
pituitary gland - adult, donor10196	10180-103C9	74.87	11.13	2.02
pituitary gland, adult, donor10252	10162-103A9	108.41	20.85	1.04
pituitary gland, adult, donor10258	10378-105G9	45.12	8.51	0.00
placenta, adult, pool1	10021-101D3	46.55	11.18	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	62.77	4.50	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	42.33	5.91	1.56
pons, adult, pool1	10033-101E6	58.61	8.09	0.60
postcentral gyrus, adult, pool1	10032-101E5	59.19	5.67	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	20.91	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	82.62	11.02	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	50.11	11.22	0.73
prostate cancer cell line:PC-3	10439-106E7	106.54	8.35	0.00
prostate, adult, pool1	10022-101D4	43.17	11.88	0.54
putamen, adult, donor10196	10176-103C5	56.18	10.86	1.42
putamen, adult, donor10252	10152-102I8	35.29	13.73	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	39.34	3.28	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	35.52	5.07	0.97
putamen, newborn, donor10223	10365-105F5	51.73	8.25	3.00
rectal cancer cell line:TT1TKB	10469-106I1	66.33	13.67	0.00
rectum, fetal, donor1	10067-101I4	33.38	11.13	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	65.93	21.41	1.91
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	39.76	11.18	0.00
retina, adult, pool1	10030-101E3	50.99	6.06	0.89
retinoblastoma cell line:Y79	10475-106I7	196.41	8.05	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	77.46	7.50	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	185.87	7.03	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	26.52	3.03	0.00
salivary acinar cells, donor1	11771-123I7	35.61	4.05	0.16
salivary acinar cells, donor2	11772-123I8	38.00	3.44	0.28
salivary acinar cells, donor3	11773-123I9	27.14	1.32	0.66
salivary gland, adult, pool1	10093-102C3	54.91	12.58	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	60.37	30.77	2.19
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	61.01	29.15	1.88
seminal vesicle, adult	10201-103F3	34.92	13.23	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	55.14	11.42	1.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	20.89	5.28	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	61.22	7.02	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	45.94	6.58	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	89.09	13.15	1.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	52.38	6.58	1.29
skeletal muscle - soleus muscle, donor1	10282-104F3	25.54	6.38	0.00
skeletal muscle, adult, pool1	10023-101D5	31.30	6.48	0.36
skeletal muscle, fetal, donor1	10066-101I3	12.06	6.03	1.01
skin, adult, donor1	10074-102A2	20.36	6.79	0.00
skin, fetal, donor1	10065-101I2	37.24	8.84	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	49.69	5.34	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	89.20	4.10	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	115.26	18.70	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	82.91	5.27	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	100.05	4.99	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	144.48	7.63	0.87
small intestine, adult, pool1	10024-101D6	37.86	16.01	0.84
small intestine, fetal, donor1	10064-101I1	34.64	7.13	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	57.96	3.08	1.03
smooth muscle, adult, pool1	10048-101G3	30.76	8.01	1.03
somatostatinoma cell line:QGP-1	10781-110G7	34.84	8.58	0.54
spinal cord - adult, donor10196	10181-103D1	27.99	8.95	1.38
spinal cord, adult, donor10252	10159-103A6	42.58	12.62	1.18
spinal cord, adult, donor10258	10369-105F9	29.06	2.77	0.00
spinal cord, fetal, donor1	10056-101H2	31.71	5.49	0.00
spinal cord, newborn, donor10223	10359-105E8	36.74	6.43	2.30
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	28.08	6.42	0.90
spleen, adult, pool1	10025-101D7	47.03	12.22	0.66
spleen, fetal, pool1	10044-101F8	47.28	14.86	1.19
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	99.58	6.00	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	51.27	3.99	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	46.83	5.94	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	25.02	7.43	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	54.14	19.25	2.48
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	30.50	5.08	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	37.65	2.12	0.85
stomach, fetal, donor1	10062-101H8	23.50	2.14	0.00
submaxillary gland, adult	10202-103F4	37.03	13.10	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	34.27	13.09	0.21
substantia nigra, adult, donor10258	10371-105G2	31.04	5.69	0.52
substantia nigra, newborn, donor10223	10358-105E7	21.90	3.53	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	101.34	12.15	0.69
temporal lobe, adult, pool1	10031-101E4	42.89	5.51	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	27.78	2.85	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	36.48	4.83	0.44
tenocyte, donor1	11763-123H8	23.39	6.28	0.35
tenocyte, donor2	11765-123I1	17.55	2.29	1.53
tenocyte, donor3	11768-123I4	19.65	4.82	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	220.10	19.21	1.70
teratocarcinoma cell line:NCR-G1	10798-110I6	68.44	4.78	0.31
teratocarcinoma cell line:PA-1	10807-111A6	49.90	6.82	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	132.53	13.71	2.41
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	132.36	12.10	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	116.48	20.94	2.73
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	193.47	10.42	0.98
testis, adult, pool1	10026-101D8	83.00	11.38	0.54
testis, adult, pool2	10096-102C6	65.41	18.95	0.90
thalamus - adult, donor10196	10168-103B6	27.60	3.31	1.10
thalamus, adult, donor10252	10154-103A1	47.98	12.50	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	26.17	6.16	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.99	2.96	0.66
thalamus, newborn, donor10223	10366-105F6	25.89	6.33	0.58
throat, adult	10209-103G2	29.46	7.99	1.50
throat, fetal, donor1	10061-101H7	20.72	8.53	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	97.97	5.76	0.99
thymus, adult, pool1	10027-101D9	75.46	18.29	1.39
thymus, fetal, pool1	10043-101F7	57.67	20.68	1.35
thyroid carcinoma cell line:KHM-5M	10776-110G2	49.46	6.38	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	75.15	21.51	1.96
thyroid, adult, pool1	10028-101E1	41.52	24.26	3.08
thyroid, fetal, donor1	10060-101H6	21.36	22.41	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	9.24	0.00
tongue, adult	10203-103F5	36.75	4.42	0.00
tongue, fetal, donor1	10059-101H5	17.34	5.91	0.79
tonsil, adult, pool1	10047-101G2	71.12	17.73	1.50
trachea, adult, pool1	10029-101E2	41.72	9.24	0.82
trachea, fetal, donor1	10058-101H4	28.47	6.16	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	37.20	5.67	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	123.10	11.14	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	139.76	19.59	1.41
tridermal teratoma cell line:HGRT	10694-109G1	36.15	11.42	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	26.41	11.00	0.59
umbilical cord, fetal, donor1	10057-101H3	18.78	0.00	0.00
uterus, adult, pool1	10100-102D1	60.23	10.24	1.88
uterus, fetal, donor1	10055-101H1	34.30	11.26	0.00
vagina, adult	10204-103F6	20.68	27.79	2.58
vein, adult	10191-103E2	33.76	11.40	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	28.57	5.07	0.80